| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |